Regarding specificity, we have recently shown that the chimeric fluorophore-conjugated CEA antibody used in the present study demonstrated more effective labeling of human CEA-expressing cancer in tissue arrays and in patient-derived orthotopic xenograft (PDOX) nude models of human patient colon cancer. The gene discussed is CEACAM5; the disease is colonic neoplasm.